The trial served as a test of the so-called amyloid hypothesis. The idea is that Alzheimer’s is intimately linked to the accumulation of amyloid in the brain; i

The trial served as a test of the so-called amyloid hypothesis. The idea is that Alzheimer’s is intimately linked to the accumulation of amyloid in the brain; if amyloid accumulation can be prevented or reversed, the disease may be prevented or cured. Pharmaceutical companies have spent billions of dollars testing anti-amyloid drugs to no avail... (Dr. Daniel Skovronsky, drug maker Eli Lilly’s chief scientific officer) has been hoping for 25 years for definitive evidence that the amyloid hypothesis is correct. “This is what we’ve been waiting for,” Dr. Skovronsky said.